| Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device. |
| |
| Trade Name | COMBI 40+COCHLEAR IMPLANT SYSTEM |
| Classification Name | implant, cochlear |
| Generic Name | cochlear implant system |
| Applicant | MED-EL CORP. |
| PMA Number | P000025 |
| Supplement Number | S017 |
| Date Received | 01/11/2005 |
| Decision Date | 07/10/2008 |
| Product Code | |
| Advisory Committee |
Ear Nose & Throat |
| Supplement Type | normal 180 day track |
| Expedited Review Granted? | No |
| Combination Product |
No
|
Approval Order Statement Approval for med-el combi 40+ cochlear implant system with pulsarci100 implants. The device, as modified, will be marketed under the trade name med-el combi 40+ cochlear implant system with pulsarci100 implants and is indicated for the following patient populations: 1) adults eighteen (18) years of age or older who have a severe to profound, bilateral sensonneural hearing loss and obtain limited benefit form appropriately fitted binaural hearing aids [note: this hearing loss may be evidenced by a bilateral pure tone average of 70 db or greater at 500, 1000 and 2000 hz and by best-aided score of <=40% correct on open-set hearing in noise test sentences (hint)]; 2) children twelve (12) months of age and older who demonstrate a profound, bilateral sensonneural hearing loss with thresholds of 90 db or greater at 1000 hz and obtain little to no benefit from appropriately fitted binaural hearing aids [note: this hearing loss in younger children may be evidenced by a lack of progress in simple auditory skill development, despite appropriate amplification and aural habitation, over a three to six-month period. This hearing loss in older children may be evidenced by a score of <20% correct on the mlnt or lnt]. |
|
|